Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate.
Iran J Basic Med Sci. 2022 Mar;25(3):313-319. doi: 10.22038/IJBMS.2022.62522.13834.
Iran J Basic Med Sci. 2022.
PMID: 35656179
Free PMC article.
In Vivo Tumor Therapy with Novel Immunotoxin Containing Programmed Cell Death Protein-1 and Diphtheria Toxin.
Mousavi A, Sabouri A, Hassanzadeh Eskafi A, Alirahimi E, Kazemi-Lomedasht F, Ghaderi H, Behdani M.
Mousavi A, et al. Among authors: hassanzadeh eskafi a.
Monoclon Antib Immunodiagn Immunother. 2021 Jun;40(3):113-117. doi: 10.1089/mab.2020.0043. Epub 2021 Jun 1.
Monoclon Antib Immunodiagn Immunother. 2021.
PMID: 34076502
Item in Clipboard
Investigation of the therapeutic potential of recombinant bispecific bivalent anti-PD-L1/VEGF nanobody in inhibition of angiogenesis.
Hassanzadeh Eskafi A, Oghalaei A, Mahboudi F, Ghaderi H, Behdani M, Shoari A, Kazemi-Lomedasht F.
Hassanzadeh Eskafi A, et al.
Immunopharmacol Immunotoxicol. 2023 Apr;45(2):197-202. doi: 10.1080/08923973.2022.2131571. Epub 2022 Oct 12.
Immunopharmacol Immunotoxicol. 2023.
PMID: 36193665
Item in Clipboard
Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model.
Salehi S, Ghaderi H, Habibi-Anbouhi M, Shoari A, Hassanzadeh Eskafi A, Sabouri A, Hosseininejad-Chafi M, Ashja Ardalan A, Ramezani B, Kazemi-Lomedasht F, Behdani M.
Salehi S, et al. Among authors: hassanzadeh eskafi a.
Iran J Pharm Res. 2023 Jan 19;21(1):e132329. doi: 10.5812/ijpr-132329. eCollection 2022 Dec.
Iran J Pharm Res. 2023.
PMID: 36896323
Free PMC article.
Item in Clipboard
Cite
Cite